Navigation Links
Drug-Device Combination Market Worth US$18.54 Billion by 2014
Date:7/28/2009

WILMINGTON, Delaware, July 28 /PRNewswire/ -- According to a new market research report, 'Drug-Device Combination Market (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total drug-device combination market is expected to be worth US$18.54 billion by 2014, out of which the U.S. market will account for nearly 30.9% of the total revenues. The global market is expected to record a CAGR of 11.8% from 2009 to 2014.

Browse 144 market data tables and in-depth TOC on drug-device market. Early buyers will receive 10% customization of reports

http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combinati

on-101.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug-device combination market ( http://www.marketsandmarkets.com/ Market-Reports/drug-and-device-combination-101.html ) includes all the products that are a combination of drugs and devices and can be chemically or physically united or co-packaged as separate, cross labeled products. The market is driven by the growing demand for treating only the ; targeted area, increasing incidences of infections associated with regular medical devices, need for faster healing, and overall reduced cost of treatment and accelerated approval process of the drug-device combination products.

(Due to the length of the URL in the above paragraph, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug eluting stents (DES) market is the larges
'/>"/>

SOURCE MarketsandMarkets
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
2. 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
3. Combination Therapy Best for Aggressive Prostate Cancer
4. Particle Sciences Further Expands Combination Product Development Capabilities
5. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
6. Abbotts TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
7. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
8. 2-drug combination appears safe and active in metastatic kidney cancer
9. New treatment combination proves safe for head and neck cancer patients
10. Study shows drug combination improves outcome for advanced non-small cell lung cancer
11. Chemotherapy combination outcomes differ for aged, younger colon cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...rdan Fiddle Foundation, a national autism organiza...d support programs and services for adolescents an... released a free informational brochure entitled &...gnize The Signs and Basic First Aid When You Do.&q...B) December 1, 2009 -- Statistics show that as man...
(Date:12/1/2009)...re/ -- What many spa clients have thought for year... proclaimed in the 2009 AsiaSpa Awards: Thailand i...tations including "Asian Spa Capital of the Year",...AsiaSpa Awards, presented by AsiaSpa magazine, the...tion, during a glittering ceremony recently in Hon...
(Date:12/1/2009)...he annual meeting of the Radiological Society of N...accurate means of identifying placenta accreta, a ...on condition that is the leading cause of death fo...Due to the increase in cesarean sections and other..., coupled with women giving birth later in life, t...
(Date:12/1/2009)...could lead to early degeneration in the spine, acc...eting of the Radiological Society of North America...ssociation between increased body mass index (BMI)...dy,s lead author, Judah G. Burns, M.D., fellow in ...al at Montefiore in New York City. , In this re...
(Date:11/30/2009).../ -- Being overweight as a child could lead to ear... presented today at the annual meeting of the Radi...his is the first study to show an association betw...malities in children," said the study,s lead autho...oradiology at The Children,s Hospital at Montefior...
Breaking Medicine News(10 mins):Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 2Health News:Thailand - Spa Capital of Asia by Karen Emmons 3Health News:Thailand - Spa Capital of Asia by Karen Emmons 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 5Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:Overweight Children may Develop Back Pain and Spinal Abnormalities 2
...tration, Evaluation and Authorization of Chemicals...ling safe chemicals to the// manufacturers. ...ke use of only safe chemicals for safety of thei...iament has approved this legislation on the use of...
...rst ever "five-star" hospital, which has seen mass... Day. // Half of the rooms of the "five-star...others and babies, have been reserved. Traditional...ulnerable to evil spirits during this period. ...
...e loss of central vision has shown promise in stem... which involves the same central// light-sensitive...e scientists report. Encouraged by the effe...cular edema, one of many complications of diabetes...
...air. To tackle obesity in school children, and inc...posal to include yoga in the// school curriculum w...l from the HRD ministry. While announcing th...chers who would take yoga classes. We will also st...
...ate (BBIC) is a natural soy-based substance. A US ...animals with a disease similar to multiple// scler...ephalomyelitis (EAE) received BBIC, while another ... get the drug were not," said the study leader Dr....
...including enlarged or painful breast tissue, but t...rs from Mayo Clinic Cancer Center. // Mammograms a...s, which are very rare in males. Their study,...s for men, who are most often diagnosed with non-c...
Other Medicine News:Health News:Drug Treatment Slows Macular Vision Loss in Diabetics 2Health News:Use of Mammograms in Men 2
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Cardiac Defibr... ,, http://www.reportlinker.com/p0164315/Cardi...e-Report.html ,, Cardiovascular disease (CVD).... Sudden cardiac arrest survivors are prone to arr...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Outsourcing Op..., http://www.reportlinker.com/p0165747/Outsour..., Report Description ,, Medical devices form ... with an estimated size of $250 billion in 2009 an...
(Date:11/30/2009)...VINA, Calif., Nov. 30 StemCyte, In...ation agreement with Academia Sinica, the National...hods and Intellectual Property (IP) related to the...s method and IP was pioneered by a team led by Pro...inica. Professor Lin is currently the exclusive c...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 1Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 2Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 1Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 2Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 1Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 2
...Apr 11, 2007 - A comparison of,the long-term econo...es combined with symptom management versus symptom...ramer acetate,injection) was the most cost-effecti...iple sclerosis (RRMS). The study provides,the firs...eness of,multiple sclerosis (MS) therapies that in...
...Apr 11, 2007 - Gloucester,Pharmaceuticals, Inc., a...unced today that several abstracts covering,precli...e 2007,Annual Meeting of the American Association ... April 14-18, 2007. These,presentations will focus... multiple academic collaborators of the Company. F...
Other Medicine Technology:First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 2First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 3First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 4First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 5First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 6Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 2Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 3
NitEye The Dry Eye Comforter
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
Medicine Products: